The World Health Organization (WHO) has also launched an alert regarding the multisystem inflammatory syndrome that has been observed in children and adolescents and appears to be related to Covid-19. On the basis of reports from Europe and the United States of children hospitalized in intensive care for a systemic inflammation condition with some characteristics similar to Kawasaki disease, WHO has developed a preliminary definition to classify these cases in children and pointed out that it is in-depth analysis required.
In the EU 230 cases – In total in the European Union about 230 suspected cases have been reported so far among children of the new Covid-19 associated multi-system inflammatory syndrome, including two deaths, one in France and the other in the United Kingdom. The symptoms, including fever, abdominal pain and heart problems, are a mixture of Kawasaki syndrome and toxic shock syndrome, as reported by a bulletin from the European Center for Disease Control (ECDC).
Currently, the ECDC notes, epidemiological studies have shown that children between 0 and 14 years of age seem to be less affected by the SARS-CoV-2 virus: they represent only 2.1% of all cases confirmed in the laboratory.
However, several European countries affected by the epidemic have recently reported cases of children hospitalised in intensive care for a rare multi-system inflammatory syndrome, which has been hypothesised to be linked to Covid-19, since many of these children have tested positive for coronavirus. The link between Covid-19 and this paediatric disease has not yet been confirmed with certainty, although it appears plausible.
The ECDC continues to consider the overall risk of Covid-19 for children in Europe low, based on the likelihood of having the disease and its moderate impact. While the clinical management of these children has absolute priority, the collection of data from the EU member states and the United Kingdom should help to understand better, according to the European Center, this rare condition and allow a better analysis of cases, clarifying its incidence, identifying the most affected age groups and risk factors.
At European level, however, an agreement has been reached to include this disease among the possible complications of Covid-19 and we are invited to inform healthcare professionals and parents about its symptoms.